(Q53159452)
Statements
Phase I pharmacokinetic/pharmacodynamic study of MLN8237, an investigational, oral, selective aurora a kinase inhibitor, in patients with advanced solid tumors (English)
Andres Cervantes
Elena Elez
Desamparados Roda
Jeffrey Ecsedy
Teresa Macarulla
Karthik Venkatakrishnan
Jordi Andreu
Jungah Jung
Juan Manuel Sanchis-Garcia
Adelaida Piera
Inma Blasco
Laura Maños
Howard Fingert